Literature DB >> 10454717

Ocular myasthenia gravis: predictive value of single-fiber electromyography.

D H Weinberg1, J F Rizzo, M T Hayes, M D Kneeland, J J Kelly.   

Abstract

Extraocular muscle weakness is the most common presenting sign of myasthenia gravis (MG). More than half of patients presenting with symptoms isolated to these muscles (OMG) develop generalized myasthenia gravis (GMG) over the course of their illness. No clinical, laboratory, or electrophysiological features are recognized that identify these high-risk patients. We have therefore assessed the ability of single-fiber electromyography (SFEMG) to predict the development of GMG in patients presenting with OMG. Thirty-nine consecutive patients presenting with OMG underwent SFEMG of the extensor digitorum communis muscle as well as a battery of other laboratory and imaging studies at the time of diagnosis. All patients were followed prospectively for a minimum of 24 months or until they developed GMG. Two patients were excluded, leaving 37 for assessment. Twenty remained with pure OMG for the entire follow-up period (mean, 55 months). Twenty-six of the 37 had abnormal SFEMG studies at presentation. Eleven of these remained with OMG and 15 developed GMG. Fifty-eight percent of patients with an abnormal SFEMG developed GMG, whereas 82% of those with a normal study remained with OMG. Thus, a normal SFEMG was associated with MG remaining restricted to the extraocular muscles. (P = 0.036, Fisher's exact test), but an abnormal SFEMG was not predictive of subsequent development of GMG. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10454717     DOI: 10.1002/(sici)1097-4598(199909)22:9<1222::aid-mus8>3.0.co;2-r

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

1.  Ocular Myasthenia Gravis.

Authors:  Victoria S. Pelak; Steven L. Galetta
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

Review 2.  Advances in myasthenia gravis.

Authors:  Emma Ciafaloni; Donald B Sanders
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

3.  Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: How much can one rely on exaggerated deep tendon reflexes.

Authors:  Keivan Basiri; Behnaz Ansari; Ali Asghar Okhovat
Journal:  Adv Biomed Res       Date:  2015-02-23

4.  Single-fiber electromyography in the orbicularis oculi muscle in patients with ocular myasthenia gravis symptoms: does abnormal jitter predict response to treatment?

Authors:  Goran Rakocevic; Mark Moster; Mary Kay Floeter
Journal:  BMC Neurol       Date:  2017-06-07       Impact factor: 2.474

Review 5.  Controversies in Ocular Myasthenia Gravis.

Authors:  Amelia Evoli; Raffaele Iorio
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

6.  Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.

Authors:  Sarah Hoffmann; Jana Siedler; Alexander U Brandt; Sophie K Piper; Siegfried Kohler; Christian Sass; Friedemann Paul; Ralf Reilmann; Andreas Meisel
Journal:  BMC Neurol       Date:  2015-12-23       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.